Centre Léon Bérard

Lyon 10 trials 4 recruiting

10 Registered trials

4 Currently recruiting

Organisation

Centre Léon Bérard

Location

Lyon, France

Identifier

ORL-000002079

Address

28 rue Laennec, cedex 08, 69373, France

Departments

Department of Medical Oncology
hepatogastroentérologie
Medical Oncology
Oncologie
Oncologie médicale
Oncology
Oncology for pediatrics
Pediatric oncology department
Service de cancérologie médicale

Clinical trials at this site (10)

Search interface

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Pending

2024-518326-32-00 Patients with advanced solid malignancies that have pro 7
Study PACIFIC: Fixed duration treatment with combined pirtobrutinib and short course immuno-chemotherapy in fit patients with previously unt… Pending

2025-521199-80-00 Patients with previously untreated symptomatic chronic 4
Mirvetuximab soravtansine in combination with bevacizumab for the maintenance treatment of adult patients with FRα-high recurrent platinum-s… Recruiting

2022-501606-35-01 Platinum-sensitive epithelial ovarian, fallopian tube, 11 2024-02-21
A global phase III study to investigate the effectiveness and safety of rilvegostomig plus chemotherapy to that of pembrolizumab plus chemot… Recruiting

2024-514281-39-00 Metastatic Squamous Non-small Cell Lung Cancer Whose Tu 5 2025-02-14
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
Phase 1b study investigating the association of NP137 with Atezolizumab-Bevacizumab combination in first line in unresectable hepatocellular… Ended

2022-500903-38-00 unresectable hepatocellular carcinoma 3 2023-02-09
This is a multicenter, randomized, Phase 3 study with vimseltinib or placebo in patients with Tenosynovial Giant Cell Tumor, consisting of 2… Ended

2024-513624-42-00 Tenosynovial Giant Cell Tumor 5 2021-12-16
A randomized, open-label, controlled phase III trial comparing the pembrolizumab platinum based chemotherapy combination with pembrolizumab … Ended

2024-513697-22-00 non-small-cell lung cancer 5 2024-11-07
EPI-7386 in Combination with Enzalutamide versus Enzalutamide alone in Metastatic Castration-Resistant Prostate Cancer Ended

2023-509336-25-00 Metastatic castration-resistant prostate cancer 9 2024-06-12